Intravitreal injection of triamcinolone: an emerging treatment for diabetic macular edema.

Editor’s comment: From time to time, treatments for diabetes and its complications are promulgated, which seem to have sufficient nonrandomized clinical data to support their consideration for use in our patients. Rather than wait for randomized clinical trials to be published (and in some cases, this is unlikely to occur), descriptions of these treatments, their effectiveness, and their side effects will be published in Diabetes Care as a Commentary. In many situations, these therapeutic approaches would only be considered after more conventional therapy has been ineffective. Intraocular injections of glucocorticoids for macular edema fit these criteria.